Sg3 Management, LLC 180 Life Sciences Corp. Call Options Transaction History

Sg3 Management, LLC

  • $0
  • Q3 2023

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$5.11 - $10.81 $332,150 - $702,650
-65,000 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$6.7 - $11.98 $167,500 - $299,500
-25,000 Reduced 27.78%
65,000 $650,000
Q1 2021

May 17, 2021
BUY
$2.51 - $6.96 $225,899 - $626,400
90,000 New
90,000 $590,000

About 180 Life Sciences Corp.

ATNF Quotes by TradingView
  • Ticker ATNF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,698,900
  • Market Cap $81.1M
  • Description
  • 1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...
More about ATNF
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email